Literature DB >> 23389394

Inhibition of the stem cell marker nestin reduces tumor growth and invasion of malignant melanoma.

Michiko Akiyama, Yoko Matsuda, Toshiyuki Ishiwata, Zenya Naito, Seiji Kawana.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23389394     DOI： 10.1038/jid.2012.508

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  15 in total

1.  Prognostic significance of neural stem cell markers, Nestin and Musashi-1, in oral squamous cell carcinoma: expression pattern of Nestin in the precancerous stages of oral squamous epithelium.

Authors:  Gokulan Ravindran; Halagowder Devaraj
Journal:  Clin Oral Investig       Date:  2014-10-29       Impact factor: 3.573

2.  Reply to a letter to the editor: Nestin as a novel therapeutic target for cancer.

Authors:  Yoko Matsuda; Shoko Kure; Toshiyuki Ishiwata
Journal:  Med Mol Morphol       Date:  2013-02-21       Impact factor: 2.309

3.  Quantitative Proteomics Links the Intermediate Filament Nestin to Resistance to Targeted BRAF Inhibition in Melanoma Cells.

Authors:  Marisa Schmitt; Tobias Sinnberg; Nicolas C Nalpas; Annika Maass; Birgit Schittek; Boris Macek
Journal:  Mol Cell Proteomics       Date:  2019-03-19       Impact factor: 5.911

4.  RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G1/S arrest via Akt-GSK3β-Rb pathway.

Authors:  Xu-Hui Yang; Tian Xia; Jie Zhang; Shao-Fen Yang; Hui-Xia Tang; Ting Tang; Zhi-Cheng Huang; Yue-Si Zhong; Feng He; Andy Peng Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

5.  Leukotriene Synthesis Is Critical for Medulloblastoma Progression.

Authors:  Fang Du; Larra Yuelling; Eric H Lee; Yuan Wang; Shengyou Liao; Yan Cheng; Li Zhang; Chaonan Zheng; Suraj Peri; Kathy Q Cai; Jessica M Y Ng; Tom Curran; Peng Li; Zeng-Jie Yang
Journal:  Clin Cancer Res       Date:  2019-07-12       Impact factor: 12.531

Review 6.  Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.

Authors:  Jean-Michel Lemée; Anne Clavreul; Philippe Menei
Journal:  Neuro Oncol       Date:  2015-07-22       Impact factor: 12.300

7.  RNA interference-mediated knockdown of SIRT1 and/or SIRT2 in melanoma: Identification of downstream targets by large-scale proteomics analysis.

Authors:  Melissa J Wilking-Busch; Mary A Ndiaye; Xiaoqi Liu; Nihal Ahmad
Journal:  J Proteomics       Date:  2017-09-05       Impact factor: 4.044

8.  Clinicopathological characteristics of malignant melanomas of the skin and gastrointestinal tract.

Authors:  Michiko Akiyama; Yoko Matsuda; Tomio Arai; Hidehisa Saeki
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

9.  UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling.

Authors:  Anushka Dikshit; Yingai J Jin; Simone Degan; Jihwan Hwang; Matthew W Foster; Chuan-Yuan Li; Jennifer Y Zhang
Journal:  Cancer Res       Date:  2018-09-17       Impact factor: 12.701

10.  Nestin depletion induces melanoma matrix metalloproteinases and invasion.

Authors:  Chung-Wei Lee; Qian Zhan; Cecilia Lezcano; Markus H Frank; John Huang; Allison R Larson; Jennifer Y Lin; Marilyn T Wan; Ping-I Lin; Jie Ma; Sonja Kleffel; Tobias Schatton; Christine G Lian; George F Murphy
Journal:  Lab Invest       Date:  2014-11-03       Impact factor: 5.662
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.